Paris : As we already predicted that H1N1 Swine flu jabs to be approved in Europe and Safety Of "Swine Flu" jab to be tested after being used.European drug regulator already allows Novartis to sell "H1N1 Swine Flu" Jab on basis of trial sponsored by Novartis.
Ignoring the fact that back in 2008 Novartis was forced to withdraw "Bird Flu" vaccine because of clinical study slaws
Earlier European Centre for Disease Control and Prevention admits "swine flu" virus not severe
But still European drugs regulators recommended Baxter's (Science journalist filed criminal charges against Baxter ) Celvapan vaccine against H1N1 flu for approval on Friday and said it expected the shot to get a licence from the European Commission "shortly".
The recommendation from the European Medicines Agency (EMEA) comes after its expert committee on new drugs also gave a green light last week to the first H1N1 swine flu vaccines from GlaxoSmithKline (GSK.L) and Novartis (NOVN.VX), called Pandemrix and Focetria.Now question is why they are pushing so hard and answer is because European Medicines Agency gets about two thirds of funds from pharma industry...